NOVEL BENZODIAZEPINE DERIVATIVE
    6.
    发明公开
    NOVEL BENZODIAZEPINE DERIVATIVE 失效
    关于BENZODIAZEPINDERIVAT。

    公开(公告)号:EP0591529A1

    公开(公告)日:1994-04-13

    申请号:EP92900534.6

    申请日:1991-12-17

    摘要: A novel benzodiazepine derivative represented by general formula (I), a pharmaceutically acceptable salt thereof, a pharmaceutical composition thereof, and a process for producing the same. In formula (I), R¹ represents optionally substituted aryl, five-membered monocyclic group, six-membered monocyclic group or aromatic heterocyclic group comprising five-membered and six-membered rings; and R² represents optionally substituted aryl. The compound (I) has a CCK-B receptor antagonism and an action of inhibiting pentagastrin-stimulated gastric secretion and hence is useful in treating and preventing the diseases wherein a CCK-B receptor and a gastrin receptor participate.

    摘要翻译: 一种由通式(I)表示的新型苯并二氮杂衍生物,其药学上可接受的盐,其药物组合物及其制备方法。 在式(I)中,R 1表示任选取代的芳基,五元单环基,六元单环基或含有五元和六元环的芳族杂环基; 且R 2表示任选取代的芳基。 化合物(I)具有CCK-B受体拮抗作用和抑制五肽胃泌素刺激的胃分泌的作用,因此可用于治疗和预防CCK-B受体和胃泌素受体参与的疾病。